Skip to main content
. 2023 Oct 25;37(12):2346–2355. doi: 10.1038/s41375-023-02042-4

Fig. 4. Comparison of OS for tisagenlecleucel vs. SOC according to subgroup categories, adjusted comparison, Forest plot, FAS.

Fig. 4

CI Confidence interval, HR Hazard ratio, HSCT Hematopoietic stem cell transplantation, MLL Mixed-lineage leukemia, n.a. not available, OS Overall survival. Note: For this subgroup analysis fine stratification weights were applied from main analysis; only subgroups for which patients were available in both arms are presented; p-value calculated by log-rank test; interaction p-value calculated by using likelihood ratio test.